Cannabis Science Inc (fka CBIS)

[boodlebing]

IMPORTANT INFORMATION PLEASE READ
Just to give you guys an idea of how big CBIS will be please check out GWPharmaceuticals at http://www.gwpharm.com/ GWPharmaceuticals is a UK based company that developed the cannabis based Sativex. Their company is publicly traded on the London Stock Exchange. GWPharmaceuticals is currently trading at $101.00 PER SHARE which is equivalent to $160.00 PER SHARE. CBIS is going to be the next GWPharmaceuticals but BIGGER in the United States! Reason being, CBIS has an incredible management team that has a great deal of intelligence (beyond what our minds can handle). Next, CBIS is going along with their well designed plan, making sure that each step is executed to perfection, having SAFETY as one of their top priorities. The most important thing you should know is that CBIS is working on their Cannabis Based drugs that will be in the forms of extracts, tinctures, and edibles. Right now they are mainly focused on designing their drugs to cure Post Traumatic Stress Disorder and Chronic Pain. The BIG difference between GWPharm and CBIS is that CBIS is going to make their products safer and more appealing to their customers. GWPharm's Sativex drug causes some irritations that are very unappealing to their customers. Some other things you guys should know; in order for Cannabis Science to get the results they want at the FDA clinical trials they are taking all the approaches necessary. They are currently using their drugs to treat patients for Nonprofit and Profit to gain as much scientific evidence as possible to use for the FDA clinical trials. The more scientific evidence they have the easier it will be for FDA approval. Cannabis Science has been negotiating with many different investors / investor groups, the advantage of this would be smoother FDA trials, more research and scientific experiments, more contracts with dispensaries. CBIS is also interested in expanding their business into other countries that would open even MORE opportunities. Cannabis Sciences' current contract with Rockbrook Dispensary is another promising revenue stream that will INCREASE in $ over certain increments of time. As far as the contract breach that Montana Pain Management broke with CBIS, the CBIS law team is handling that case, hoping to win and make some extra cash! Cannabis Science is supposed to be announcing the dividends information in the upcoming weeks. The recent Prop 19 is a bonus that will help draw even MORE attention to this stock. One more thing to think about, last time I talked to Mark from Cannabis Science Investor Relations he told me the following words, "Imagine if someone famous, like a famous celebrity who had cancer was cured by our drug." And I asked him you guys cured a celebrity? And he wouldn't answer my question. I found that to be very interesting and suspenseful! Anyways, I hope you guys learned some things you didn't know before about CBIS. When I found out about this stock, and I found out what they were all about, I knew their was no way in the world I was going to miss out on this. I remember buying this stock at $0.21 a few months ago, and I sold on a small loss, then I got back in at the $0.0X's and I have been holding ever since.. Even this stock in the $0.20 range is a hell of a bargain right now.. We were at $1.50 a few months ago and that was when nothing SPECIAL was going on.. Can you imagine what we will be at when everything starts to roll out as planned?!?!?!? GOOOOOOOOOOOOOOOOOOOOO CBIS!!!!!!!!!!!!!!